@samfiodiving
On your point Sam of the minimum deal you would be happy with… that is the mediocre deal I was referring to.. $200m upfront. A good deal is double that and half the equity. The equity point may be the sticking point in negotiations.. you get equity if its a great deal.. I believe Roche got about 4.5% of Sarepta equity.. any more than 8% of the company is a blocking stake and can limit longer term potential upside.
See how we go.
Chart, page-4252
-
- There are more pages in this discussion • 1,654 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
